MMNFF logo

MedMen Enterprises Inc. (MMNFF)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

MedMen Enterprises Inc. (MMNFF) with AI Score 43/100 (Weak). MedMen Enterprises Inc. cultivates, produces, distributes, and retails recreational and medicinal cannabis in the United States. Market cap: 0, Sector: Healthcare.

Last analyzed: Mar 17, 2026
MedMen Enterprises Inc. cultivates, produces, distributes, and retails recreational and medicinal cannabis in the United States. The company operates 29 stores across multiple states under the MedMen Red and LuxLyte brand names.
43/100 AI Score

MedMen Enterprises Inc. (MMNFF) Healthcare & Pipeline Overview

CEOMelony Valleau CPA
Employees428
HeadquartersCulver City, US
IPO Year2018

MedMen Enterprises Inc. is a cannabis company operating in the United States, focusing on cultivation, production, distribution, and retail of recreational and medicinal cannabis. With a presence in key states, MedMen competes in a rapidly evolving market landscape with a negative profit margin of -117.6%.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 17, 2026

Investment Thesis

MedMen Enterprises Inc. operates in the rapidly growing cannabis industry but faces significant financial challenges. With a negative P/E ratio and a profit margin of -117.6%, the company's profitability is a major concern. The company's gross margin of 49.5% indicates potential in its core operations, but high operating expenses are hindering overall profitability. Key growth catalysts include expansion into new markets and increased legalization of cannabis. However, the company's high beta of 1.40 suggests significant volatility. Investors should closely monitor MedMen's ability to improve its financial performance and navigate the competitive landscape. The company's success depends on effective execution of its growth strategy and efficient management of its operations.

Based on FMP financials and quantitative analysis

Key Highlights

  • Operates 29 stores across multiple states as of December 25, 2021, indicating a substantial retail presence.
  • Cultivates, produces, distributes, and retails recreational and medicinal cannabis, offering a vertically integrated business model.
  • Gross margin of 49.5% suggests potential for profitability if operating expenses are managed effectively.
  • Negative profit margin of -117.6% highlights significant financial challenges and the need for improved cost management.
  • High beta of 1.40 indicates significant volatility, reflecting the speculative nature of the cannabis industry.

Competitors & Peers

Strengths

  • Established brand recognition in the cannabis industry.
  • Vertically integrated operations provide control over the supply chain.
  • Retail footprint in key cannabis markets.
  • Focus on premium branding and high-quality products.

Weaknesses

  • Negative profit margin and significant financial losses.
  • High operating expenses.
  • Intense competition in the cannabis industry.
  • Regulatory uncertainty and evolving state-level laws.

Catalysts

  • Upcoming: Potential for expansion into new markets as more states legalize cannabis.
  • Ongoing: Increasing consumer acceptance of cannabis and growing demand for cannabis products.
  • Ongoing: Product innovation and development of new cannabis strains and products.

Risks

  • Ongoing: Intense competition in the cannabis industry.
  • Potential: Regulatory changes and stricter enforcement of cannabis laws.
  • Ongoing: Financial losses and negative profit margin.
  • Potential: Economic downturns that could reduce consumer spending on cannabis.
  • Ongoing: Limited financial disclosure due to OTC listing.

Growth Opportunities

  • Expansion into New Markets: As more states legalize cannabis for recreational and medicinal use, MedMen has the opportunity to expand its retail footprint and cultivation operations into new markets. This expansion can drive revenue growth and increase market share. The timeline for this growth depends on the pace of legalization in different states, but the long-term potential is significant. Successfully entering new markets requires navigating complex regulatory frameworks and establishing strong local partnerships.
  • Increased Legalization of Cannabis: The ongoing trend of cannabis legalization at the state and federal levels presents a significant growth opportunity for MedMen. As more states legalize cannabis, the market size expands, and MedMen can reach a larger customer base. The timeline for this growth is dependent on legislative changes, but the overall trend is positive. Federal legalization would be a major catalyst, opening up interstate commerce and reducing regulatory burdens.
  • Product Innovation and Branding: MedMen can drive growth by developing new and innovative cannabis products that cater to evolving consumer preferences. This includes creating new strains, edibles, and other cannabis-infused products. Building a strong brand reputation for quality and consistency is also crucial for attracting and retaining customers. The timeline for this growth is ongoing, as MedMen continuously invests in research and development and marketing efforts.
  • Enhancing Retail Experience: MedMen can differentiate itself from competitors by providing a superior retail experience. This includes creating visually appealing stores, offering knowledgeable and friendly customer service, and providing a wide selection of high-quality products. Enhancing the retail experience can attract more customers and increase sales. The timeline for this growth is ongoing, as MedMen continuously invests in improving its store design and customer service.
  • Strategic Partnerships and Acquisitions: MedMen can accelerate its growth through strategic partnerships and acquisitions. This includes partnering with other cannabis companies to expand its product offerings or entering into joint ventures to enter new markets. Acquisitions can provide MedMen with access to new technologies, brands, or retail locations. The timeline for this growth is opportunistic, as MedMen evaluates potential partnerships and acquisitions on an ongoing basis.

Opportunities

  • Expansion into new markets as more states legalize cannabis.
  • Increased legalization of cannabis at the federal level.
  • Product innovation and development of new cannabis products.
  • Strategic partnerships and acquisitions to expand market reach.

Threats

  • Increased competition from other cannabis companies.
  • Changing consumer preferences and demand for different cannabis products.
  • Regulatory changes and stricter enforcement of cannabis laws.
  • Economic downturns that could reduce consumer spending on cannabis.

Competitive Advantages

  • Brand recognition: MedMen has established a well-known brand in the cannabis industry.
  • Retail footprint: Operates a network of retail stores in key markets.
  • Vertically integrated operations: Controls the entire supply chain from cultivation to retail.
  • Proprietary strains and products: Develops unique cannabis strains and products.

About MMNFF

MedMen Enterprises Inc. was founded with the vision of mainstreaming cannabis and setting a new standard for the cannabis industry. The company cultivates, produces, distributes, and retails recreational and medicinal cannabis products. MedMen's brands include MedMen Red and LuxLyte, catering to different consumer segments within the cannabis market. As of December 25, 2021, MedMen operated 29 stores across California, Florida, Nevada, Illinois, Arizona, Massachusetts, and New York. The company is headquartered in Culver City, California. MedMen aims to provide a premium retail experience and high-quality cannabis products, focusing on compliance and responsible operations. However, the company faces significant challenges, including financial losses and intense competition in the evolving cannabis market. The company's strategy involves expanding its retail footprint, enhancing its brand portfolio, and optimizing its supply chain to improve profitability and market share. MedMen's focus on key markets like California and Florida reflects its strategy to capitalize on high-growth opportunities in the cannabis sector.

What They Do

  • Cultivates cannabis plants.
  • Produces cannabis products, including flower, edibles, and concentrates.
  • Distributes cannabis products to its retail stores.
  • Operates retail stores that sell recreational and medicinal cannabis.
  • Markets and brands its cannabis products under the MedMen Red and LuxLyte brands.
  • Ensures compliance with state and local regulations.
  • Provides customer service and education about cannabis products.

Business Model

  • Vertically integrated: controls cultivation, production, distribution, and retail.
  • Generates revenue through the sale of cannabis products in its retail stores.
  • Focuses on premium branding and high-quality products.
  • Operates in states with legal recreational and/or medicinal cannabis markets.

Industry Context

MedMen operates in the rapidly expanding cannabis industry, driven by increasing legalization and changing consumer attitudes. The market is characterized by intense competition, evolving regulations, and varying state-level laws. Companies like MedMen are vying for market share in key states such as California, Florida, and Illinois. The industry is projected to continue growing, with estimates varying widely depending on regulatory changes and market adoption. MedMen's ability to navigate this complex landscape and differentiate itself through branding, product quality, and retail experience will be crucial for its success.

Key Customers

  • Adults aged 21 and over seeking recreational cannabis products.
  • Patients with medical conditions who are authorized to use medicinal cannabis.
  • Cannabis connoisseurs seeking high-quality and unique products.
  • Tourists visiting states with legal cannabis markets.
AI Confidence: 69% Updated: Mar 17, 2026

Financials

Chart & Info

MedMen Enterprises Inc. (MMNFF) stock price: Price data unavailable

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MMNFF.

Price Targets

Wall Street price target analysis for MMNFF.

MoonshotScore

43/100

What does this score mean?

The MoonshotScore rates MMNFF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Melony Valleau CPA

Unknown

Melony Valleau is a CPA who is managing 428 employees at MedMen Enterprises Inc. More information about her background, career history, education, and previous roles is not available in the provided data. Her expertise as a CPA likely brings financial acumen to the leadership role within the company, which is particularly important given the company's current financial challenges.

Track Record: Due to limited information, Melony Valleau's specific achievements, strategic decisions, and company milestones under her leadership cannot be assessed. Her impact on the company's performance and strategic direction remains unknown based on the available data.

MMNFF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that MedMen Enterprises Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance. Investing in companies on the OTC Other tier carries higher risks due to the lack of regulatory oversight and potential for fraud or manipulation. This tier is often populated by shell companies, bankrupt entities, or companies with questionable business practices.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Liquidity on the OTC market, particularly for OTC Other tier stocks, can be limited. This can result in wider bid-ask spreads and difficulty in buying or selling shares without significantly impacting the price. Low trading volume can also increase volatility and make it challenging to execute large trades. Investors should be aware of these liquidity risks before investing in MMNFF.
OTC Risk Factors:
  • Limited financial disclosure increases the risk of investing in MMNFF.
  • Low liquidity can make it difficult to buy or sell shares.
  • Higher potential for fraud or manipulation on the OTC Other tier.
  • Lack of regulatory oversight compared to major exchanges.
  • Potential for delisting or trading suspension.
Due Diligence Checklist:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Review the company's legal and regulatory compliance.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
  • Check for any history of regulatory actions or legal disputes.
Legitimacy Signals:
  • Operation of 29 stores in multiple states as of December 25, 2021.
  • Cultivation, production, distribution, and retail of cannabis products.
  • Established brands (MedMen Red and LuxLyte).
  • Presence in a regulated industry (cannabis).
  • Managing 428 employees.

Common Questions About MMNFF

What does MedMen Enterprises Inc. do?

MedMen Enterprises Inc. operates as a cannabis company in the United States, focusing on the cultivation, production, distribution, and retail of recreational and medicinal cannabis. The company manages a chain of retail stores under the MedMen Red and LuxLyte brand names, offering a range of cannabis products to consumers and patients. MedMen aims to provide a premium retail experience and high-quality cannabis products, while navigating the complex regulatory landscape of the cannabis industry. The company's vertically integrated business model allows it to control the entire supply chain, from cultivation to retail sales.

What do analysts say about MMNFF stock?

Based on available data, there is no analyst coverage information provided for MMNFF stock. Given that it trades on the OTC market, particularly the OTC Other tier, it is less likely to have extensive analyst coverage compared to companies listed on major exchanges like the NYSE or NASDAQ. Investors should conduct their own thorough research and due diligence before investing in MMNFF, considering the limited availability of analyst opinions and financial information.

What are the main risks for MMNFF?

MedMen Enterprises Inc. faces several significant risks, including intense competition in the cannabis industry, regulatory uncertainty and evolving state-level laws, and ongoing financial losses with a negative profit margin. The company's listing on the OTC Other tier also presents risks related to limited financial disclosure, low liquidity, and potential for fraud or manipulation. Economic downturns could reduce consumer spending on cannabis, impacting MedMen's revenue. Investors should carefully consider these risks before investing in MMNFF.

What are the key factors to evaluate for MMNFF?

MedMen Enterprises Inc. (MMNFF) currently holds an AI score of 43/100, indicating low score. Key strength: Established brand recognition in the cannabis industry.. Primary risk to monitor: Ongoing: Intense competition in the cannabis industry.. This is not financial advice.

How frequently does MMNFF data refresh on this page?

MMNFF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven MMNFF's recent stock price performance?

Recent price movement in MedMen Enterprises Inc. (MMNFF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brand recognition in the cannabis industry.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider MMNFF overvalued or undervalued right now?

Determining whether MedMen Enterprises Inc. (MMNFF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying MMNFF?

Before investing in MedMen Enterprises Inc. (MMNFF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Limited information available on the company's financials and operations.
  • OTC listing increases the risk of investing in MMNFF.
  • AI analysis pending for MMNFF.
Data Sources

Popular Stocks